Beta Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 6, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	11,084	19,235	11,861	6,027	5,437	1,038
Market Cap Growth	-37.41%	62.17%	96.79%	10.87%	423.79%	200.00%
Enterprise Value	11,316	19,147	11,782	6,023	5,446	1,127
Last Close Price	1098.00	1905.50	1175.00	597.10	538.57	114.29
PE Ratio	27.77	45.35	32.55	19.62	21.90	8.85
PS Ratio	2.88	5.31	4.01	2.65	2.96	0.89
PB Ratio	5.02	9.76	7.55	4.91	5.89	1.51
P/TBV Ratio	5.23	10.20	7.82	5.10	6.17	1.59
P/FCF Ratio	-	-	61.41	116.57	53.30	8.08
P/OCF Ratio	-	53.22	38.35	25.78	18.35	5.58
EV/Sales Ratio	2.94	5.28	3.98	2.65	2.96	0.97
EV/EBITDA Ratio	15.25	26.06	19.67	11.27	12.75	4.55
EV/EBIT Ratio	19.04	30.84	23.50	14.00	15.37	6.29
EV/FCF Ratio	-	-	61.00	116.49	53.39	8.77
Debt / Equity Ratio	0.66	0.70	0.09	0.17	0.22	0.26
Debt / EBITDA Ratio	1.96	1.88	0.25	0.38	0.48	0.70
Debt / FCF Ratio	-	-	0.76	3.93	2.02	1.36
Net Debt / Equity Ratio	0.11	-0.05	-0.09	0.01	0.04	0.10
Net Debt / EBITDA Ratio	0.31	-0.12	-0.23	0.02	0.08	0.28
Net Debt / FCF Ratio	-	12.56	-0.72	0.23	0.32	0.55
Asset Turnover	-	1.05	1.31	1.27	1.34	1.03
Inventory Turnover	-	3.88	4.51	4.88	5.83	5.09
Quick Ratio	-	2.54	1.42	1.43	1.42	1.45
Current Ratio	-	3.22	2.10	2.03	1.98	2.04
Return on Equity (ROE)	-	23.95%	26.03%	28.54%	30.85%	18.65%
Return on Assets (ROA)	-	11.24%	13.85%	15.10%	16.09%	9.97%
Return on Invested Capital (ROIC)	18.41%	27.91%	28.04%	29.31%	29.96%	17.56%
Return on Capital Employed (ROCE)	-	18.60%	29.60%	31.80%	32.60%	21.30%
Earnings Yield	3.74%	2.21%	3.07%	5.10%	4.57%	11.30%
FCF Yield	-	-0.04%	1.63%	0.86%	1.88%	12.38%
Buyback Yield / Dilution	-10.48%	-5.00%	4.76%	-	-	-1.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.